2ayp
From Proteopedia
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
| - | Chk1 inhibitors have emerged as a novel class of neoplastic agents for | + | Chk1 inhibitors have emerged as a novel class of neoplastic agents for abrogating the G2 DNA damage checkpoint arrest. Analogs of the Chk1 inhibitor, 3-ethylidene-1,3-dihydro-indol-2-one, were synthesized and tested in vitro for their inhibitory activities. The most promising compound identified from this series is analog 28, which possesses potent enzymatic and cellular activities. |
==About this Structure== | ==About this Structure== | ||
| Line 16: | Line 16: | ||
[[Category: Chen, Z.]] | [[Category: Chen, Z.]] | ||
[[Category: Kovar, P.]] | [[Category: Kovar, P.]] | ||
| - | [[Category: Lin, N | + | [[Category: Lin, N H.]] |
| - | [[Category: Rosenberg, S | + | [[Category: Rosenberg, S H.]] |
| - | [[Category: Sham, H | + | [[Category: Sham, H L.]] |
[[Category: Xia, P.]] | [[Category: Xia, P.]] | ||
[[Category: Zhang, H.]] | [[Category: Zhang, H.]] | ||
| Line 24: | Line 24: | ||
[[Category: protein-inhibitor complex]] | [[Category: protein-inhibitor complex]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:32:30 2008'' |
Revision as of 14:32, 21 February 2008
|
Crystal Structure of CHK1 with an Indol Inhibitor
Overview
Chk1 inhibitors have emerged as a novel class of neoplastic agents for abrogating the G2 DNA damage checkpoint arrest. Analogs of the Chk1 inhibitor, 3-ethylidene-1,3-dihydro-indol-2-one, were synthesized and tested in vitro for their inhibitory activities. The most promising compound identified from this series is analog 28, which possesses potent enzymatic and cellular activities.
About this Structure
2AYP is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.
Reference
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors., Lin NH, Xia P, Kovar P, Park C, Chen Z, Zhang H, Rosenberg SH, Sham HL, Bioorg Med Chem Lett. 2006 Jan 15;16(2):421-6. Epub 2005 Oct 18. PMID:16242328
Page seeded by OCA on Thu Feb 21 16:32:30 2008
